News

A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Providence Cancer Institute lung cancer expert to present a virtual education talk on lung cancer screening, prevention and latest treatments.

Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.

Providence Heart Institute welcomed patients and their families for the clinic’s third anniversary of its advanced heart failure clinic.

Providence Cancer Institute celebrates Advanced Practice Providers Week from September 25 to 29 and recognizes their important contributions more than 25 clinics and programs.

Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.

The Springs Living has made a generous gift to Providence Foundations of Oregon to establish The Springs Living Regional Chair of Geriatric Medical Education.

For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.

New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.

Early next year an expansion of our Warrenton Clinic will begin to bring more services to the North Coast community.

Two breast cancer survivors whose stories intersect in a miraculous way, threw the first pitches at the Medford Rogues annual Paint the Park Pink event. Read their story.